Radja F, el Mansari M, Soghomonian J J, Dewar K M, Ferron A, Reader T A, Descarries L
Département de Physiologie, Faculté de Médecine, Université de Montréal, Québec, Canada.
Neuroscience. 1993 Dec;57(3):635-48. doi: 10.1016/0306-4522(93)90011-4.
The specific binding of [3H]SCH23390 to D1 and of [3H]raclopride to D2 dopamine receptors was measured by autoradiography in the rostral and caudal halves of neostriatum and in the substantia nigra of adult rats subjected to near total destruction of nigrostriatal dopamine neurons by intraventricular 6-hydroxydopamine soon after birth. Three months after this lesion, [3H]SCH23390 binding (D1 receptors) was slightly but significantly decreased in the rostral neostriatum (22%), but unchanged in its caudal half and in the substantia nigra. In contrast, [3H]raclopride binding (D2 receptors) was considerably increased throughout the neostriatum (10-40%), while markedly decreased in the substantia nigra (80%). In the rostral neostriatum, there were no parallel changes in D2 receptor messenger RNA levels, as measured by in situ hybridization on adjacent sections. Caudally, however, slight but significant increases in D2 messenger RNA could be observed (10-20%). As assessed by quantitative iontophoresis, there was a marked enhancement (63%) of the inhibitory responsiveness of spontaneously firing units in the rostral neostriatum to dopamine and the D1 agonist, SKF38393, in neonatally lesioned compared to control rats. On the other hand, responsiveness to PPHT, a potent D2 agonist, appeared to be unchanged. Such opposite changes in the number of D1 and D2 binding sites, dissociated from the expression of D2 receptor messenger RNA and from the sensitivity to dopamine and D1 and D2 agonists, suggested independent adaptations of these various parameters following the neonatal dopamine denervation of neostriatum. They also provided further evidence for mechanisms other than the dopamine innervation in the control of the expression of neostriatal D2 receptor messenger RNA during ontogenesis, and emphasized that the effects of dopamine and its D1 and D2 agonists in neostriatum do not depend strictly on the number of D1 and D2 primary ligand recognition sites.
通过放射自显影法,测量出生后不久经脑室内注射6-羟基多巴胺使黑质纹状体多巴胺神经元几乎完全损毁的成年大鼠的新纹状体头端和尾端以及黑质中,[3H]SCH23390与D1多巴胺受体的特异性结合和[3H]雷氯必利与D2多巴胺受体的特异性结合。损伤后三个月,[3H]SCH23390结合(D1受体)在新纹状体头端略有但显著下降(22%),而在其尾端和黑质中未发生变化。相反,[3H]雷氯必利结合(D2受体)在整个新纹状体中显著增加(10 - 40%),而在黑质中显著下降(80%)。在新纹状体头端,通过对相邻切片进行原位杂交测量,D2受体信使核糖核酸水平没有平行变化。然而,在尾端,可以观察到D2信使核糖核酸有轻微但显著的增加(10 - 20%)。通过定量离子电渗法评估,与对照大鼠相比,新生期损伤大鼠新纹状体头端自发放电单位对多巴胺和D1激动剂SKF38393的抑制反应性显著增强(63%)。另一方面,对强效D2激动剂PPHT的反应性似乎未发生变化。D1和D2结合位点数量的这种相反变化,与D2受体信使核糖核酸的表达以及对多巴胺和D1及D2激动剂的敏感性相分离,表明新纹状体新生期多巴胺去神经支配后,这些不同参数发生了独立的适应性变化。它们还为个体发育过程中除多巴胺神经支配外控制新纹状体D2受体信使核糖核酸表达的机制提供了进一步证据,并强调多巴胺及其D1和D2激动剂在新纹状体中的作用并不严格取决于D1和D2主要配体识别位点的数量。